The primary aim of this study is to measure zinc status and related proteins in patients with Thalassemia who have or do not have diabetes. The secondary aim will be to explore the effect of zinc supplementation on glucose metabolism in patients with thalassemia. It is estimated that the study, which started in November 2012, will be completed in December 2014.

More information: clinicaltrials.gov, ITHANET Clinical Trials